These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathogenesis of hepatic fibrosis and the role of cytokines. Lissoos TW; Davis BH J Clin Gastroenterol; 1992 Jul; 15(1):63-7. PubMed ID: 1500664 [TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitors of metalloproteinases in liver fibrosis. Iredale JP Int J Biochem Cell Biol; 1997 Jan; 29(1):43-54. PubMed ID: 9076940 [TBL] [Abstract][Full Text] [Related]
4. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice. An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229 [TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis and altered matrix synthesis. Neubauer K; Saile B; Ramadori G Can J Gastroenterol; 2001 Mar; 15(3):187-93. PubMed ID: 11264572 [TBL] [Abstract][Full Text] [Related]
6. Genesis of hepatic fibrosis and its biochemical markers. Das SK; Vasudevan DM Scand J Clin Lab Invest; 2008; 68(4):260-9. PubMed ID: 18609066 [TBL] [Abstract][Full Text] [Related]
8. [Cytokines in the pathogenesis of liver fibrosis]. Flisiak R Przegl Lek; 1999; 56(9):604-7. PubMed ID: 10695368 [TBL] [Abstract][Full Text] [Related]
9. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. Li D; Friedman SL J Gastroenterol Hepatol; 1999 Jul; 14(7):618-33. PubMed ID: 10440206 [TBL] [Abstract][Full Text] [Related]
10. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Gressner AM; Weiskirchen R J Cell Mol Med; 2006; 10(1):76-99. PubMed ID: 16563223 [TBL] [Abstract][Full Text] [Related]
11. Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis. Kawser CA; Iredale JP; Winwood PJ; Arthur MJ Clin Sci (Lond); 1998 Aug; 95(2):179-86. PubMed ID: 9680500 [TBL] [Abstract][Full Text] [Related]
12. Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis. Prestigiacomo V; Weston A; Messner S; Lampart F; Suter-Dick L PLoS One; 2017; 12(6):e0179995. PubMed ID: 28665955 [TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. McCrudden R; Iredale JP Histol Histopathol; 2000 Oct; 15(4):1159-68. PubMed ID: 11005241 [TBL] [Abstract][Full Text] [Related]
14. [The roles of Kupffer cells in the development and regression of liver fibrosis]. Wu JY; Liu GT Yao Xue Xue Bao; 2008 Sep; 43(9):884-9. PubMed ID: 19048777 [TBL] [Abstract][Full Text] [Related]
15. New aspects of hepatic fibrosis. Brenner DA; Waterboer T; Choi SK; Lindquist JN; Stefanovic B; Burchardt E; Yamauchi M; Gillan A; Rippe RA J Hepatol; 2000; 32(1 Suppl):32-8. PubMed ID: 10728792 [TBL] [Abstract][Full Text] [Related]
16. Hepatic stellate cells and the reversal of fibrosis. Kisseleva T; Brenner DA J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681 [TBL] [Abstract][Full Text] [Related]